Renal and metabolic adverse effects of lithium therapy;Complication renales et metaboliques du lithium

Nephrologie

Volumn 21, Issue 2, 2000, Pages 65-70

  Kanfer, Alain ^a   Blondiaux, L ^a  

^a HÔPITAL TENON   (France)

Author keywords

Hypercalcemia; Hyperparathyroidism; Lithium; Nephrogenic diabetes insipidus

Indexed keywords

AMILORIDE; DESMOPRESSIN; LITHIUM; ANTIDEPRESSANT AGENT; CALCITRIOL; CALCIUM; ELECTROLYTE; LITHIUM CARBONATE; PARATHYROID HORMONE; PHOSPHATE; PLASMA PROTEIN; THYROTROPIN; VASOPRESSIN DERIVATIVE;

AGED; ARTICLE; CASE REPORT; DRUG CLEARANCE; DRUG EFFECT; FEMALE; FLUID BALANCE; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPOTHYROIDISM; KIDNEY CONCENTRATING CAPACITY; KIDNEY DISEASE; KIDNEY FUNCTION; MANIC DEPRESSIVE PSYCHOSIS; METABOLIC DISORDER; NEPHROGENIC DIABETES INSIPIDUS; ANIMAL; BIPOLAR DISORDER; BLOOD; CHEMICALLY INDUCED DISORDER; DIABETES INSIPIDUS; METABOLISM; RAT; TIME;

AGED; ANIMALS; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; BLOOD PROTEINS; CALCITRIOL; CALCIUM; DIABETES INSIPIDUS; ELECTROLYTES; FEMALE; HUMANS; LITHIUM CARBONATE; PARATHYROID HORMONE; PHOSPHATES; RATS; THYROTROPIN; TIME FACTORS; VASOPRESSINS;

EID: 0033658433     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Baylis PH, Heat DA. Water disturbances in patients treated with oral lithium carbonate Ann Int Med 1978; 88: 607-9.
2. Wallin L, Ailing C, Aurell M. Impairment of renal function in patients on long-term lithium treatment. Clin Nephrol 1982; 18: 23-8.
3. Hansen HE, Pedersen EB, Orskov H, Vestergaard P, Amdisen A, Schou M. Plasma arginine-vasopressin, renal-concentrating ability and lithium excretion in a group of patients on long-term lithium treatment. Nephron 1982; 32: 125-30.
4. Boton R, Gaviria M, Batlle DC. Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis 1987; 5: 329-45.
5. Bendz H, Aurell M, Balldin J, Mathé AA, Sjödin I. Kidney damage in long-term lithium patients: A cross-sectional study of patients with 15 years or more on lithium. Nephrol Dial Transplant 1994; 9: 1250-4.
6. Walker RG. Lithium nephrotoxicity. Kidney Int 1993; 44 (Suppl. 42): S93-S8.
7. Marples D, Christensen S, Christensen El, Ottosen PD, Nielsen S. Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla. J Clin Invest 1995; 95: 1838-45.
8. Nielsen S, Kwon TH, Monster Christensen B, Promeneur D, Froklaer J, Marples D. Physiology and pathophysiology of renal aquaporins. J Am Soc Nephrol 1999; 10: 647-63.
9. Hensen J, Haenelt M, Gross P. Lithium induced polyuria and renal vasopressin receptor density. Nephrol Dial Transplant 1996; 11: 622-7.
10. Fujimura A, Ohashi K, Ebihara A. Inflyence of repeated administration of lithium on urinary excretion of prostaglandins in rats. Jpn J Pharmacol 1991; 57: 565-9
11. Hochberg Z, Even L, Danon A. Amelioration of polyuria in nephrogenic diabetes insipidus due to aquaporin-2 deficiency. Clin Endocrinol 1998, 49: 39-44.
12. 2 receptors modulate water and sodium transport in rabbit cortical collecting duct. Am J Physiol 1993; 265: F643-F50.
13. Breyer MD, Jacobson HR, Breyer RM. Functional and molecular aspects of renal prostaglandin receptors. J Am Soc Nephrol 1996; 7: 8-17.
14. Dobrowolski L, Kompanowska-Jezierska E, Sadowski J. Modulation of renal medullary ionic hypertonicity by prostaglandins: Date from tissue admittance studies in the rat. J Physiol (Lond) 1995; 485: 827-34.
15. MacGregor DA, Baker AM, Appel RG, Ober KP, Zaloga GP. Hyperosmolar coma due to lithium-induced diabetes insipidus. Lancet 1995; 346: 413-7.
16. Lam SS, Kjellstrand C. Emergency treatment of lithium-induced diabetes insipidus with nonsteroidal anti-inflammatory drugs. Ren Fail 1997; 19: 183-8.
17. Batlle DC, Riotte AB, Gaviria M, Grupp M. Amelioration of polyuria by amiloride in patients receiving long-term lithium therapy. N Engl J Med 1985; 312: 408-14.
18. Kosten TR, Forrest JN. Treatment of severe lithium-induced polyuria with amiloride. Am J Psychiatry 1986; 143: 1563-8.
19. Abramow M, Cogan E. Rôle de l'interaction lithium-ADH dans la pathuogénie de la polyurie du lithium. Actual Néphrol Hôp Necker. Paris: Flammarion, 1983; 131-5.
20. Miller PD, Dubovsky SL, McDonald KM, Katz FH, Robertson GL, Schrier RW. Central, renal and adrenal effects of lithium in man. Am J Med 1979; 66: 797-803.
21. Dafnis E, Kurtzman NA, Sabatini S. Effect of lithium and amiloride on collecting tubule transport enzymes. J Pharmacol Exp Ther 1992; 261: 701-6.
22. Hansen HE, Hestbech J, Sorensen JL, Norgaard K, Heilskov J, Amdisen A. Chronic interstitial nephropathy in patients on long-term lithium treatment. Q J Med 1979; 192: 577-91.
23. Donker AJM, Prins E, Meijer S, Sluiter WJ, Van Berkestijn JWBM, Dols LCW. A renal function study in 30 patients on long-term lithium therapy. Clin Nephrol 1979; 13: 254-62.
24. Phan L, Coulomb F, Boudon M, Gallois H, Kleinknecht D. Glomérulonéphrite extramembraneuse induite par le lithium. Néphrologie 1991; 12: 185-7.
25. Bosquet S, Descombes E, Gauthier T, Fellay G, Regamey C. Nephrotic syndrome during lithium therapy. Nephrol Dial Transplant 1997; 12: 2728-31.
26. Hansen HA, Amdisen A. Lithium intoxication. Q J Med 1978; 47: 123-44.
27. Timmer R, Sands JM. Lithium intoxication. J Am Soc Neph 1999; 10: 666-74.
28. Bateman AM, Larner AJ, McCartney SA, Rifkin IR. Rhabdomyolysis associated with lithium-induced hyperosmolal state. Nephrol Dial Transplant 1991; 6: 203-5.
29. Stancer HC, Forbath N. Hyperparathyroidism, hypothyroidism, and impaired renal function after 10 to 20 years of lithium treatment. Arch Intern Med 1989; 149: 1042-5.
30. Bendz H, Sjodin I, Toss G, Breglund K. Hyperparathyroidism and long-term lithium therapy a cross-sectional study and the effect of lithium withdrawal. J Intern Med 1996; 240: 357-65.
31. De Celis G, Fiter M, Latorre X, Llebaria C. Oxyphilic parathyroid adenoma and lithium therapy. Lancet 1998; 352: 1070.
32. McHenry CR, Racke F, Meister M, Warnaka P, Sarasua M, Nemeth EF, Malangoni MA. Lithium effects on dispersed bovine parathyroid cells grown in tissue culture. Surgery 1991; 110: 1061-6.
33. Birnbaum J, Klandorf H, Giuliano A, Van Herle A. Lithium stimulated the release of human parathyroid hormone in vitro. J Clin Endocrinol Metab 1988; 66: 1187-91.
34. Saxe AW, Gibson G. Lithium increases tritiated thymidine uptake by abnormal human parathyroid tissue. Surgery 1991; 110: 1067-76.
35. Koppelberg T, Bartsch D, Printz H, Hasse C, Rothmund M. Pancreatitis in primary hyperparathyroidism is a complication of advanced pHPT. Dtsch Med Wochenschr 1994; 119: 719-24.
36. Salata R, Klein I. Effects of lithium on the endocrine system: A review. J Lab Clin Med 1987; 110: 130-6.
37. Dusing R, Herrmann R, Glanzer K, Vetter H, Overlack A, Kramer HJ. Renal prostaglandins and water balance: Studies in normal volunteer subjects and in patients with central diabetes insipidus. Clin Sci 1981; 61: 61-7.
38. 2α in diabetes insipidus rats. Am J Physiol 1978; 235: E624-E7.
39. 2 production. Prostaglandins Leukot Essent Fatty Acids 1998; 58: 157-62.
40. Rascher W, Rosendahl W, Henrichs IA, Maier R, Seyberth HW. Congenital nephrogenic diabetes insipidus-vasopressin and prostaglandins in response to treatment with hydrochlorothiazide and indomethacin. Pediatr Nephrol 1987; 1: 485-90.
41. Hohler T, Teuber G, Wanitschke R, Meyer Zum Buschenfeld KH. Indomethacin treatment in amphotericin B induced nephrogenic diabetes insipidus. Clin Investig 1994; 72: 769-71.
42. Delaney V, De Pertuz Y, Nixon D, Bourke E. Indomethacin in streptozotocin-induced nephrogenic diabetes insipidus. Am J Kidney Dis 1987; 9: 79-83.